HYAL3 as a potential novel marker of BLCA patient prognosis.
- Published in:
- BMC Genomic Data, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12863-022-01070-w
- By:
- Publication type:
- Article
Works matching AU Fang, Yu-Tong
Results: 3
1
2
HYAL3 as a potential novel marker of BLCA patient prognosis.
- Published in:
- BMC Genomic Data, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12863-022-01070-w
- By:
- Publication type:
- Article
3
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-85537-7
- By:
- Publication type:
- Article